• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动与慢性冠状动脉缺血:一个具有挑战性的恶性循环。

Atrial Fibrillation and Chronic Coronary Ischemia: A Challenging Vicious Circle.

作者信息

Oancea Alexandru Florinel, Jigoranu Raul Alexandru, Morariu Paula Cristina, Miftode Radu-Stefan, Trandabat Bogdan Andrei, Iov Diana Elena, Cojocaru Elena, Costache Irina Iuliana, Baroi Livia Genoveva, Timofte Daniel Vasile, Tanase Daniela Maria, Floria Mariana

机构信息

Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy Grigore T. Popa, 700115 Iasi, Romania.

Cardiology Clinic, St. Spiridon Emergency Hospital, 700115 Iasi, Romania.

出版信息

Life (Basel). 2023 Jun 12;13(6):1370. doi: 10.3390/life13061370.

DOI:10.3390/life13061370
PMID:37374152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10305229/
Abstract

Atrial fibrillation, the most frequent arrhythmia in clinical practice and chronic coronary syndrome, is one of the forms of coronary ischemia to have a strong dual relationship. Atrial fibrillation may accelerate atherosclerosis and may increase oxygen consumption in the myocardium, creating a mismatch between supply and demand, thus promoting the development or worsening of coronary ischemia. Chronic coronary syndrome alters the structure and function of gap junction proteins, affecting the conduction of action potential and leading to ischemic necrosis of cardiomyocytes and their replacement with fibrous tissue, in this way sustaining the focal ectopic activity in atrial myocardium. They have many risk factors in common, such as hypertension, obesity, type 2 diabetes mellitus, and dyslipidemia. It is vital for the prognosis of patients to break this vicious circle by controlling risk factors, drug therapies, of which antithrombotic therapy may sometimes be challenging in terms of prothrombotic and bleeding risk, and interventional therapies (revascularization and catheter ablation).

摘要

心房颤动是临床实践中最常见的心律失常,与慢性冠状动脉综合征一样,是具有强烈双重关系的冠状动脉缺血形式之一。心房颤动可能会加速动脉粥样硬化,并可能增加心肌的氧消耗,造成供需不匹配,从而促进冠状动脉缺血的发展或恶化。慢性冠状动脉综合征会改变缝隙连接蛋白的结构和功能,影响动作电位的传导,导致心肌细胞缺血坏死并被纤维组织替代,从而维持心房肌的局灶性异位活动。它们有许多共同的危险因素,如高血压、肥胖、2型糖尿病和血脂异常。通过控制危险因素、药物治疗(其中抗血栓治疗在血栓形成和出血风险方面有时可能具有挑战性)以及介入治疗(血运重建和导管消融)来打破这种恶性循环对患者的预后至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9575/10305229/1ff018b6879c/life-13-01370-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9575/10305229/28b22c5f4e60/life-13-01370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9575/10305229/121f48058298/life-13-01370-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9575/10305229/7a9e20a81d40/life-13-01370-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9575/10305229/1ff018b6879c/life-13-01370-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9575/10305229/28b22c5f4e60/life-13-01370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9575/10305229/121f48058298/life-13-01370-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9575/10305229/7a9e20a81d40/life-13-01370-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9575/10305229/1ff018b6879c/life-13-01370-g004.jpg

相似文献

1
Atrial Fibrillation and Chronic Coronary Ischemia: A Challenging Vicious Circle.心房颤动与慢性冠状动脉缺血:一个具有挑战性的恶性循环。
Life (Basel). 2023 Jun 12;13(6):1370. doi: 10.3390/life13061370.
2
Spectrum of Non-Obstructive Coronary Artery Disease and Its Relationship with Atrial Fibrillation.非阻塞性冠状动脉疾病的谱及其与心房颤动的关系。
J Clin Med. 2024 Aug 21;13(16):4921. doi: 10.3390/jcm13164921.
3
Coronary heart disease and atrial fibrillation: a vicious cycle.冠心病与心房颤动:恶性循环。
Am J Physiol Heart Circ Physiol. 2021 Jan 1;320(1):H1-H12. doi: 10.1152/ajpheart.00702.2020. Epub 2020 Nov 13.
4
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.房颤合并冠状动脉疾病患者的三联与双联抗栓治疗
Am J Med. 2016 Jun;129(6):592-599.e1. doi: 10.1016/j.amjmed.2015.12.026. Epub 2016 Jan 18.
5
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes.达比加群双重治疗与华法林三联治疗用于伴有糖尿病的房颤患者经皮冠状动脉介入术后
JACC Cardiovasc Interv. 2019 Dec 9;12(23):2346-2355. doi: 10.1016/j.jcin.2019.07.059.
6
Trends of Antithrombotic Treatment in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights from the GReek-AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.经皮冠状动脉介入治疗的心房颤动患者抗栓治疗趋势:来自希腊抗血小板心房颤动(GRAPE-AF)登记研究的见解。
Cardiovasc Drugs Ther. 2021 Feb;35(1):11-20. doi: 10.1007/s10557-020-07090-x. Epub 2020 Oct 9.
7
Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.非瓣膜性心房颤动患者行经皮冠状动脉介入治疗后发生卒中和脑出血的风险:比较双联与三联抗栓治疗的随机对照试验的系统评价和荟萃分析。
J Stroke Cerebrovasc Dis. 2021 Apr;30(4):105654. doi: 10.1016/j.jstrokecerebrovasdis.2021.105654. Epub 2021 Feb 10.
8
[Impact of different antithrombotic therapy strategy on prognosis in coronary heart disease patients combining with atrial fibrillation: a meta analysis].[不同抗栓治疗策略对合并心房颤动冠心病患者预后的影响:一项Meta分析]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jun 24;45(6):526-535. doi: 10.3760/cma.j.issn.0253-3758.2017.06.016.
9
Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.急性冠状动脉综合征或经皮冠状动脉介入治疗后早期和晚期心房颤动患者抗栓治疗的风险/获益权衡:来自 AUGUSTUS 的见解。
Circulation. 2020 May 19;141(20):1618-1627. doi: 10.1161/CIRCULATIONAHA.120.046534. Epub 2020 Mar 29.
10
Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.心房颤动伴急性或慢性冠状动脉疾病的口服抗血栓治疗。
Can J Cardiol. 2013 Jul;29(7 Suppl):S60-70. doi: 10.1016/j.cjca.2013.04.006.

引用本文的文献

1
Clinical Outcomes of Oral Anticoagulation in Elderly East Asian Patients with Atrial Fibrillation: A Retrospective Single-Center Study.东亚老年房颤患者口服抗凝治疗的临床结局:一项回顾性单中心研究
Life (Basel). 2025 Aug 15;15(8):1298. doi: 10.3390/life15081298.
2
Structure of Comorbidities and Causes of Death in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease.心房颤动合并慢性阻塞性肺疾病患者的共病结构及死亡原因
J Clin Med. 2025 Jul 16;14(14):5045. doi: 10.3390/jcm14145045.
3
Atrial Fibrillation Risk Scores as Potential Predictors of Significant Coronary Artery Disease in Chronic Coronary Syndrome: A Novel Diagnostic Approach.

本文引用的文献

1
Atrial fibrillation and coronary artery disease: An integrative review focusing on therapeutic implications of this relationship.心房颤动与冠状动脉疾病:一项聚焦于这种关系治疗意义的综合综述。
World J Cardiol. 2023 May 26;15(5):229-243. doi: 10.4330/wjc.v15.i5.229.
2
Atrial fibrillation fundamentals: from physiopathology to transcatheter ablation.心房颤动基础:从病理生理学到经导管消融
Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C7-C11. doi: 10.1093/eurheartjsupp/suad003. eCollection 2023 May.
3
Syndecan-1: From a Promising Novel Cardiac Biomarker to a Surrogate Early Predictor of Kidney and Liver Injury in Patients with Acute Heart Failure.
心房颤动风险评分作为慢性冠状动脉综合征中严重冠状动脉疾病的潜在预测指标:一种新型诊断方法。
Life (Basel). 2025 Jul 18;15(7):1134. doi: 10.3390/life15071134.
4
A Case of Intraoperative Reproducible Transient Bradycardia During Total Hip Arthroplasty: Direct Activation of Parasympathetic Vagal Afferents From Bone.全髋关节置换术中一例可术中重现的短暂性心动过缓:来自骨骼的迷走神经副交感传入神经直接激活
Case Rep Anesthesiol. 2025 Jun 23;2025:5583839. doi: 10.1155/cria/5583839. eCollection 2025.
5
Galectin-3 and Pentraxin-3 as Potential Biomarkers in Chronic Coronary Syndrome and Atrial Fibrillation: Insights from a 131-Patient Cohort.半乳糖凝集素-3和五聚素-3作为慢性冠状动脉综合征和心房颤动的潜在生物标志物:来自131例患者队列的见解
Int J Mol Sci. 2025 May 20;26(10):4909. doi: 10.3390/ijms26104909.
6
Exploring patterns of multimorbidity in South Korea using exploratory factor analysis and non negative matrix factorization.使用探索性因素分析和非负矩阵分解探索韩国的多重疾病模式。
Sci Rep. 2025 Mar 22;15(1):9885. doi: 10.1038/s41598-025-94338-x.
7
Atrial Fibrillation as an Independent Predictor of Myocardial Ischemia.心房颤动作为心肌缺血的独立预测因素。
Medicina (Kaunas). 2025 Feb 14;61(2):337. doi: 10.3390/medicina61020337.
8
Atrial Fibrillation Types and Chronic Kidney Disease are Independent Predictors of Atrial Fibrillation Recurrence After Radiofrequency Ablation.心房颤动类型和慢性肾脏病是射频消融术后心房颤动复发的独立预测因素。
Ther Clin Risk Manag. 2024 Dec 3;20:817-828. doi: 10.2147/TCRM.S492265. eCollection 2024.
9
Correlations Between Plasma BNP Level and Risk of Thrombotic-Hemorrhagic Events After Left Atrial Appendage Closure.血浆脑钠肽水平与左心耳封堵术后血栓形成-出血事件风险的相关性
J Clin Med. 2024 Oct 18;13(20):6232. doi: 10.3390/jcm13206232.
10
Hospital Utilization and Mortality Post-electrical Cardioversion in Patients With Atrial Fibrillation in a Community Hospital.社区医院房颤患者电复律后的住院情况及死亡率
Cureus. 2024 Aug 15;16(8):e66919. doi: 10.7759/cureus.66919. eCollection 2024 Aug.
Syndecan-1:从一个有前景的新型心脏生物标志物到急性心力衰竭患者肾脏和肝脏损伤的替代早期预测指标。
Life (Basel). 2023 Mar 28;13(4):898. doi: 10.3390/life13040898.
4
Provocation and Localization of Arrhythmogenic Triggers from Persistent Left Superior Vena Cava in Patients with Atrial Fibrillation.房颤患者持续性左上腔静脉致心律失常触发因素的诱发与定位
J Clin Med. 2023 Feb 23;12(5):1783. doi: 10.3390/jcm12051783.
5
Impact of unipolar voltage criteria for left atrial posterior wall on atrial fibrillation recurrence after pulmonary vein isolation.单极电压标准对肺静脉隔离术后左心房后壁心房颤动复发的影响。
J Cardiovasc Electrophysiol. 2023 Apr;34(4):849-859. doi: 10.1111/jce.15838. Epub 2023 Mar 26.
6
Triglyceride glucose index is associated with obstructive coronary artery disease in hypertensive patients.甘油三酯葡萄糖指数与高血压患者的阻塞性冠状动脉疾病有关。
Cardiovasc Diabetol. 2023 Jan 12;22(1):9. doi: 10.1186/s12933-023-01739-1.
7
Empirical superior vena cava isolation improves outcomes of radiofrequency re-ablation in pulmonary vein isolation non-responders: A 2-center retrospective study in China.经验性上腔静脉隔离改善肺静脉隔离无反应者射频再次消融的结局:一项在中国进行的2中心回顾性研究。
Front Cardiovasc Med. 2022 Dec 7;9:1049414. doi: 10.3389/fcvm.2022.1049414. eCollection 2022.
8
The Maine vein of Marshall ethanol experience: learning curve and safety.马歇尔乙醇治疗缅因静脉曲张学曲线和安全性。
J Interv Card Electrophysiol. 2023 Apr;66(3):661-671. doi: 10.1007/s10840-022-01378-8. Epub 2022 Oct 1.
9
Long-term outcomes of left atrial appendage isolation using cryoballoon in persistent atrial fibrillation.持续性心房颤动中使用冷冻球囊进行左心耳隔离的长期结果。
Europace. 2023 Feb 16;25(2):366-373. doi: 10.1093/europace/euac167.
10
[Metabolic syndrome and atrial fibrillation].[代谢综合征与心房颤动]
Herzschrittmacherther Elektrophysiol. 2022 Dec;33(4):367-372. doi: 10.1007/s00399-022-00898-0. Epub 2022 Sep 21.